title: Physical exercise-induced hyperinsulinemic hypoglycemia is an autosomal-dominant trait characterized by abnormal pyruvate-induced insulin release.
abstract: We have identified patients in whom strenuous physical exercise leads to hypoglycemia caused by inappropriate insulin release (exercise-induced hyperinsulinism [EIHI]). The aim of the present study was to test the hypothesis that the increased levels of lactate and/or pyruvate during anaerobic exercise would trigger the aberrant insulin secretion in these patients. A total of 12 patients (8 women and 4 men from two families) were diagnosed with EIHI, based on hypoglycemia and a more than threefold increase in plasma insulin induced by a 10-min bicycle exercise test. The mode of inheritance was autosomal dominant in these families. The acute response of insulin release to a bolus of intravenous pyruvate (13.9 mmol/1.73 m(2)) was studied in the patients and eight healthy control subjects. Insulin secretion did not respond to the pyruvate bolus in healthy control subjects. However, all EIHI patients responded to pyruvate, displaying a brisk increase in plasma insulin. The 1 + 3-min peak response was 5.6-fold in the patients and 0.9-fold in the control subjects (P < 0.001). To test the hypothesis that the pathogenesis of EIHI would involve monocarboxylate transport or metabolism in the beta-cell, we sequenced the genes encoding the known monocarboxylate transporter proteins and tested the transport of pyruvate into patient fibroblasts. The results revealed normal coding sequences and pyruvate transport. In conclusion, EIHI represents a new autosomal-dominant hyperinsulinemia syndrome that may be more common than has been realized. The pyruvate test provides a simple, safe, and specific diagnostic test for this condition.
authors.affiliation: Program for Developmental and Reproductive Biology, Biomedicum, Helsinki, Finland. timo.otonkoski@helsinki.fi
authors.forename: Timo
authors.initials: T
authors.lastname: Otonkoski
authors.forename: Nina
authors.initials: N
authors.lastname: Kaminen
authors.forename: Jarkko
authors.initials: J
authors.lastname: Ustinov
authors.forename: Risto
authors.initials: R
authors.lastname: Lapatto
authors.forename: Thomas
authors.initials: T
authors.lastname: Meissner
authors.forename: Ertan
authors.initials: E
authors.lastname: Mayatepek
authors.forename: Juha
authors.initials: J
authors.lastname: Kere
authors.forename: Ilkka
authors.initials: I
authors.lastname: Sipilä
mesh_terms: D000328:Adult; D001692:Biological Transport; D015444:Exercise / Q000502:physiology*; D005080:Exercise Test; D005260:Female; D005347:Fibroblasts / Q000378:metabolism*; D005799:Genes, Dominant; D006801:Humans; D006946:Hyperinsulinism / Q000097:blood* / Q000235:genetics*; D007003:Hypoglycemia / Q000097:blood* / Q000235:genetics*; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D027501:Monocarboxylic Acid Transporters / Q000235:genetics; D010375:Pedigree; D019289:Pyruvic Acid / Q000378:metabolism*
chemical_list: D007328:Insulin; D027501:Monocarboxylic Acid Transporters; D019289:Pyruvic Acid; D007770:L-Lactate Dehydrogenase